Incremental benefit of high dose compared to standard dose influenza vaccine in reducing hospitalizations
Abstract Evidence regarding the high-dose (HD) vaccine’s relative vaccine effectiveness (rVE) and absolute benefit in reducing influenza-related hospitalizations compared to the standard-dose (SD) vaccine is warranted. We estimated the adjusted rVE and the number needed to vaccinate (NNV) of the HD...
Saved in:
Main Authors: | Shlomit Yaron, Matan Yechezkel, Dan Yamin, Talish Razi, Ilya Borochov, Erez Shmueli, Ronen Arbel, Doron Netzer |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-025-01065-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trialResearch in context
by: Gabriela Tapia-Calle, et al.
Published: (2025-01-01) -
Comparing efficacy and safety of low-dose versus standard-dose antiplatelet therapy in stroke patients: a meta-analysis
by: Zhao Ren, et al.
Published: (2025-01-01) -
Weight-Based Standardized Sugammadex Dosing in Pediatrics: A Quality Improvement Initiative to Improve Compliance with Dosing Guidelines and Reduce Waste and Cost
by: Sydney E. S. Brown, et al.
Published: (2024-01-01) -
Efficacy and Safety of High-dose versus Standard-dose Prazosin in Paediatric Scorpion Envenomation: A Single-blinded Randomised Controlled Study
by: Apoorva Gayatri Abbadi, et al.
Published: (2025-01-01) -
The Dose Makes the Poison
by: Kerry Carney
Published: (2025-12-01)